« Previous
Next »
Journal of Surgical Research
Volume 148, Issue 2
, Pages 158-163
, August 2008
Hepatic Ischemia-Reperfusion Increases Vascular Endothelial Growth Factor and Cancer Growth in Rats
References
- Optimal cycles of hepatic ischemia and reperfusion for intermittent pedicle clamping during liver surgery. Arch. Surg. 1995;130:745
- Effect of intermittent hepatic pedicle clamping on free radical generation in the rat liver. Surgery. 1998;124:49
- Intermittent hepatic pedicle clamping reduces liver and lung damage. J Surg Res. 1998;78:11
- Hepatic ischemia-reperfusion promotes liver metastasis of colon cancer. J Surg Res. 2002;105:243
- Intermittent hepatic-reperfusion minimizes liver metastasis in rats. J Surg Res. 2003;111:255
- Intrahepatic expression and release of vascular endothelial growth factor following orthotopic liver transplantation in the rat. Transplantation. 2001;72:805
- Dual role of vascular endothelial growth factor in hepatic ischemia-reperfusion injury. Transplantation. 2005;79:1110
- Expression of vascular endothelial growth factor and its receptors KDR and Flt-1 in gastric cancer cells. World J Gastroenterol. 2002;8:994
- Melanoma-associated expression of vascular endothelial growth factor and its receptors FLT-1 and KDR. J Cancer Res Clin Oncol. 1999;125:621
- Concomitant over-expression of vascular endothelial growth factor and its receptors in pancreatic cancer. Int J Cancer. 2000;85:27
- A new rat colon cancer cell line metastasizes spontaneously biologic characteristics and chemotherapeutic response. Jpn J Cancer. 1991;82:90
- Partial hepatectomy accelerates local tumor growth: Potential roles of local cytokine activation. Surgery. 1998;124:57
- Facilitation by partial hepatectomy of tumor growth within the rat liver following intraportal injection of syngeneic tumor cells. Clin Exp Metastasis. 1991;9:335
- . Notes on the arrest of hepatic hemorrhage due to trauma. Ann Surg. 1908;48:541
- The role of cytokine networks in the local liver injury following hepatic ischemia/reperfusion in the rat. Hepatology. 1996;23:506
- Tumor-derived expression of vascular endothelial growth factor is a critical factor in tumor expansion and vascular function. Cancer Res. 1999;59:1592
- Vascular endothelial growth factor expression in serum of patients with hepatocellular carcinoma. Chin Med J (Engl). 2003;116:772
- Vascular endothelial growth factor (VEGF) is an autocrine growth factor for VEGF receptor-positive human tumors. Blood. 2001;98:1904
- Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma. Proc Natl Acad Sci USA. 1997;94:979
- Visualization of early events in tumor formation of eGFP-transfected rat colon cancer cells in liver. Hepatology. 2003;38:295
- . sFlt-1, a potential antagonist for exogenous VEGF. Circulation. 2000;102:E108
- Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate. Proc Natl Acad Sci USA. 1998;95:879
- Selection of high affinity human neutralizing antibodies to VEGFR2 from a large antibody phage display library for antiangiogenesis therapy. Int J Cancer. 2002;97:393
PII: S0022-4804(07)02433-X
doi: 10.1016/j.jss.2007.12.787
© 2008 Elsevier Inc. All rights reserved.
« Previous
Next »
Journal of Surgical Research
Volume 148, Issue 2
, Pages 158-163
, August 2008
